Optimal M-Switch Surveillance Policies for Liver Cancer in a Hepatitis C–Infected Population
From MaRDI portal
Publication:4971370
DOI10.1287/opre.2017.1706zbMath1455.90108OpenAlexW2614434583MaRDI QIDQ4971370
Turgay Ayer, Jagpreet Chhatwal, Qiushi Chen
Publication date: 12 October 2020
Published in: Operations Research (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1287/opre.2017.1706
surveillancedynamic programmingmixed integer programmingscreeningcost-effectivenesshealth policyhepatocellular carcinoma
Related Items (3)
Design of Incentive Programs for Optimal Medication Adherence in the Presence of Observable Consumption ⋮ Partially observable collaborative model for optimizing personalized treatment selection ⋮ Nonstationary Bandits with Habituation and Recovery Dynamics
Cites Work
- Unnamed Item
- Timing of testing and treatment for asymptomatic diseases
- Robust response-guided dosing
- Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors
- Dynamic Policy Modeling for Chronic Diseases: Metaheuristic-Based Identification of Pareto-Optimal Screening Strategies
- Determining the Acceptance of Cadaveric Livers Using an Implicit Model of the Waiting List
- Estimating the Patient's Price of Privacy in Liver Transplantation
- Survey of linear programming for standard and nonstandard Markovian control problems. Part I: Theory
- OR Forum—A POMDP Approach to Personalize Mammography Screening Decisions
This page was built for publication: Optimal M-Switch Surveillance Policies for Liver Cancer in a Hepatitis C–Infected Population